Veradigm Inc. (NASDAQ:MDRX) Given Consensus Recommendation of “Hold” by Analysts

Shares of Veradigm Inc. (NASDAQ:MDRX) have received a consensus rating of “Hold” from the five research firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $12.00.

Separately, StockNews.com assumed coverage on shares of Veradigm in a research report on Friday. They set a “hold” rating for the company.

Veradigm Trading Up 1.5 %

MDRX stock opened at $9.40 on Tuesday. The business’s 50 day moving average price is $9.51 and its two-hundred day moving average price is $9.19. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $13.51.

Institutional Trading of Veradigm

A number of institutional investors and hedge funds have recently modified their holdings of MDRX. Vanguard Group Inc. lifted its position in shares of Veradigm by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock valued at $149,754,000 after buying an additional 95,291 shares in the last quarter. Meadow Creek Wealth Advisors LLC purchased a new position in shares of Veradigm during the first quarter valued at approximately $83,000. Tyro Capital Management LLC purchased a new stake in shares of Veradigm in the first quarter valued at approximately $9,055,000. Finally, Innealta Capital LLC purchased a new stake in Veradigm during the second quarter worth $38,000.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.